The use of spironolactone in the diagnosis and the treatment of hypertension associated with mineralocorticoid excess
- 30 September 1973
- journal article
- review article
- Published by Elsevier in American Heart Journal
- Vol. 86 (3), 404-414
- https://doi.org/10.1016/0002-8703(73)90051-3
Abstract
No abstract availableThis publication has 84 references indexed in Scilit:
- Aldosterone: Physiological and pathophysiological variations in manClinics in Endocrinology and Metabolism, 1972
- Comparison of Surgery and Prolonged Spironolactone Therapy in Patients with Hypertension, Aldosterone Excess, and Low Plasma ReninBMJ, 1972
- Adrenal mineralocorticoids causing hypertensionAmerican Journal Of Medicine, 1972
- Hochdruck und Aldosteronismus bei solitären Adenomen und bei nodulärer Hyperplasie der NebennierenrindeKlinische Wochenschrift, 1969
- PLASMA ELECTROLYTES, RENIN, AND ALDOSTERONE IN THE DIAGNOSIS OF PRIMARY HYPERALDOSTERONISM: With a Note on Plasma-corticosterone ConcentrationThe Lancet, 1968
- Primary Aldosteronism with Suppressed Plasma Renin Activity Due to Bilateral Nodular Adrenocortical HyperplasiaAnnals of Internal Medicine, 1967
- Plasma Renin in a Case of Conn's Syndrome with Fibrinoid Lesions: Use of Spironolactone in TreatmentBMJ, 1964
- Symposium on Hypertension Hypokalemia and the Diagnosis of HypertensionDiseases of the Chest, 1964
- Potassium deficiency of renal and adrenal originAmerican Journal Of Medicine, 1957
- Adrenal cortical carcinoma producing solely mineralocorticoid effectAmerican Journal Of Medicine, 1955